JP Morgan Chase
CELU icon

JP Morgan Chase’s Celularity CELU Stock Holding History

JP Morgan Chase’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10 Hold
16
– – ﹤0.01% 7648
2026
Q1 		$20 Hold
16
– – ﹤0.01% 7409
2025
Q4 		$18 Hold
16
– – ﹤0.01% 7310
2025
Q3 		$33 Hold
16
– – ﹤0.01% 7255
2025
Q2 		$31 Sell
16
-27
-63% -$49 ﹤0.01% 6930
2025
Q1 		$75 Hold
43
– – ﹤0.01% 6913
2024
Q4 		$89 Buy
43
+27
+169% +$64 ﹤0.01% 7022
2024
Q3 		$48 Hold
16
– – ﹤0.01% 7127
2024
Q2 		$50 Hold
16
– – ﹤0.01% 7028
2024
Q1 		$84 Hold
16
– – ﹤0.01% 6937
2023
Q4 		$40 Hold
16
– – ﹤0.01% 7234
2023
Q3 		$36 Hold
16
– – ﹤0.01% 7046
2023
Q2 		$86 Sell
16
-4,863
-100% -$31.2K ﹤0.01% 6708
2023
Q1 		$30K Buy
4,879
+1,257
+35% +$10.1K ﹤0.01% 5866
2022
Q4 		$46K Sell
3,622
-42
-1% -$774 ﹤0.01% 5647
2022
Q3 		$84K Buy
3,664
+2,819
+334% +$85.5K ﹤0.01% 5362
2022
Q2 		$28K Buy
+845
New +$68.6K ﹤0.01% 5813
2021
Q2 		– Sell
-115,977
Closed -$11.7M – 6366
2021
Q1 		$11.7M Buy
115,977
+78,424
+209% +$8.04M ﹤0.01% 2217
2020
Q4 		$4.13M Sell
37,553
-2,026
-5% -$215K ﹤0.01% 2971
2020
Q3 		$4.12M Buy
+39,579
New +$4.1M ﹤0.01% 2724

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

JP Morgan Chase's CELU Position: Q2 2026 in Review

JP Morgan Chase held its Celularity (CELU) position steady in Q2 2026 at 16 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #7648.

JP Morgan Chase first reported a position in CELU in Q3 2020 and has held it in 20 quarters since. The position peaked at $11.7M in Q1 2021. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • JP Morgan Chase held 16 shares of Celularity worth $10 as of Q2 2026.
  • JP Morgan Chase left its Celularity share count unchanged in Q2 2026.
  • Celularity made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7648 holding.
  • JP Morgan Chase first reported a position in Celularity in Q3 2020 and has held it in 20 quarters since.
  • JP Morgan Chase's Celularity position peaked at $11.7M in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.